Related resources
Full-text held externally
- PMID: 23698371
- UKPMCID: 23698371
- DOI: 10.1038/nature12240
Search for item elsewhere
University researcher(s)
Academic department(s)
Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria.
Hepworth, Matthew R; Monticelli, Laurel A; Fung, Thomas C; Ziegler, Carly G K; Grunberg, Stephanie; Sinha, Rohini; Mantegazza, Adriana R; Ma, Hak-Ling; Crawford, Alison; Angelosanto, Jill M; Wherry, E John; Koni, Pandelakis A; Bushman, Frederic D; Elson, Charles O; Eberl, GĂ©rard; Artis, David; Sonnenberg, Gregory F
Nature. 2013;498(7452):113-7.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- PMID: 23698371
- UKPMCID: 23698371
- DOI: 10.1038/nature12240
Abstract
Innate lymphoid cells (ILCs) are a recently characterized family of immune cells that have critical roles in cytokine-mediated regulation of intestinal epithelial cell barrier integrity. Alterations in ILC responses are associated with multiple chronic human diseases, including inflammatory bowel disease, implicating a role for ILCs in disease pathogenesis. Owing to an inability to target ILCs selectively, experimental studies assessing ILC function have predominantly used mice lacking adaptive immune cells. However, in lymphocyte-sufficient hosts ILCs are vastly outnumbered by CD4(+) T cells, which express similar profiles of effector cytokines. Therefore, the function of ILCs in the presence of adaptive immunity and their potential to influence adaptive immune cell responses remain unknown. To test this, we used genetic or antibody-mediated depletion strategies to target murine ILCs in the presence of an adaptive immune system. We show that loss of retinoic-acid-receptor-related orphan receptor-Îłt-positive (RORÎłt(+)) ILCs was associated with dysregulated adaptive immune cell responses against commensal bacteria and low-grade systemic inflammation. Remarkably, ILC-mediated regulation of adaptive immune cells occurred independently of interleukin (IL)-17A, IL-22 or IL-23. Genome-wide transcriptional profiling and functional analyses revealed that RORÎłt(+) ILCs express major histocompatibility complex class II (MHCII) and can process and present antigen. However, rather than inducing T-cell proliferation, ILCs acted to limit commensal bacteria-specific CD4(+) T-cell responses. Consistent with this, selective deletion of MHCII in murine RORÎłt(+) ILCs resulted in dysregulated commensal bacteria-dependent CD4(+) T-cell responses that promoted spontaneous intestinal inflammation. These data identify that ILCs maintain intestinal homeostasis through MHCII-dependent interactions with CD4(+) T cells that limit pathological adaptive immune cell responses to commensal bacteria.
Bibliographic metadata
- Hepworth, Matthew R
- Monticelli, Laurel A
- Fung, Thomas C
- Ziegler, Carly G K
- Grunberg, Stephanie
- Sinha, Rohini
- Mantegazza, Adriana R
- Ma, Hak-Ling
- Crawford, Alison
- Angelosanto, Jill M
- Wherry, E John
- Koni, Pandelakis A
- Bushman, Frederic D
- Elson, Charles O
- Eberl, GĂ©rard
- Artis, David
- Sonnenberg, Gregory F
- 2-P30 CA016520, NCI NIH HHS, United States
- AI061570, NIAID NIH HHS, United States
- AI074878, NIAID NIH HHS, United States
- AI087990, NIAID NIH HHS, United States
- AI095466, NIAID NIH HHS, United States
- AI095608, NIAID NIH HHS, United States
- AI095776, NIAID NIH HHS, United States
- AI097333, NIAID NIH HHS, United States
- AI102942, NIAID NIH HHS, United States
- DK071176, NIDDK NIH HHS, United States
- DP5 OD012116, NIH HHS, United States
- DP5OD012116, NIH HHS, United States
- P01 DK071176, NIDDK NIH HHS, United States
- P30 DK050306, NIDDK NIH HHS, United States
- P30DK50306, NIDDK NIH HHS, United States
- R01 AI061570, NIAID NIH HHS, United States
- R01 AI074878, NIAID NIH HHS, United States
- R01 AI095466, NIAID NIH HHS, United States
- R01 AI097333, NIAID NIH HHS, United States
- R01 AI102942, NIAID NIH HHS, United States
- R21 AI083480, NIAID NIH HHS, United States
- R21 AI087990, NIAID NIH HHS, United States
- T32 AI007532, NIAID NIH HHS, United States
- T32 AI055428, NIAID NIH HHS, United States
- T32-AI055428, NIAID NIH HHS, United States
- U01 AI095608, NIAID NIH HHS, United States